Nivolumab-induced interstitial lung disease in the patient with melanoma by Marcin Morawski, Gabriela Trąd, Agnieszka Gawlewicz-Mroczka

Subjects: Get full text

Colitis grave inmunomediada por Nivolumab-Ipilimumab: a propósito de un caso by Maria Victoria Foglino, Ayelen Vacirca, Florencia Cabrera, Ignacio Gutierrez Magaldi, Santiago Rafael Bella

Subjects: Get full text

Efficacy and safety of nivolumab in the treatment of relapsed/refractory classical Hodgkin’s lymphoma: Pavlov First Saint Petersburg State Medical University experience by K. V. Lepik, N. V. Mikhailova, E. V. Kondakova, L. A. Tsvetkova, Yu. R. Zalyalov, E. S. Borzenkova, I. S. Moiseev, V. V. Baykov, B. A. Afanasyev

Subjects: Get full text

Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report by Koji Yasuda, Toshiaki Tanaka, Soichiro Ishihara, Kensuke Otani, Takeshi Nishikawa, Tomomichi Kiyomatsu, Kazushige Kawai, Keisuke Hata, Hiroaki Nozawa, Yuri Masui, Yukako Shintani, Toshiaki Watanabe

Subjects: “…Nivolumab…”
Get full text

Nivolumab-containing therapy in patients with newly diagnosed classical Hodgkin lymphoma: own clinical observations and literature review by D. D. Ivanova, E. A. Baryakh, M. A. Mingalimov, E. N. Misyurina, D. S. Polyakov, N. A. Savosina, M. M. Beregov, M. A. Donskoy, A. B. Makeshova, T. N. Tolstykh, O. L. Kochneva, T. S. Kravchuk, E. I. Zhelnova, K. V. Yatskov, A. Kh. Mnoyan, I. M. Grashchenko, N. A. Shevchenko, A. A. Vinokurov, I. V. Samsonova, M. A. Lysenko

Subjects: Get full text

Successful treatment of recurrent metastatic nasopharyngeal carcinoma with nivolumab: a case report by Yu. M. Bychkov, A. M. Mudunov, I. M. Gelfand, B. G. Pkheshkhova, O. D. Ryzhova, А. A. Akhundov, V. Z. Dobrokhotova, М. N. Narimanov

Subjects: Get full text

Anti-CTLA-and anti-PD-1 immune checkpoint inhibitor antibodies impair human sperm motility in-vitro by Ilaria Cosci, Luca De Toni, Paolo Del Fiore, Andrea Di Nisio, Andrea Di Nisio, Samuela Carraro, Claudia Maria Radu, Loris Bertazza, Simone Mocellin, Simone Mocellin, Jacopo Pigozzo, Giovanna Crivellaro, Marina Coppola, Alberto Ferlin

Subjects: Get full text

Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) s... by Maral Martin Mildanoglu, Yasin Kutlu, Onur Bas, Bahadır Koylu, Shute Ailia Dae, Abdullah Sakin, Dilek Erdem, Mehmet Ali Nahit Sendur, Elif Senocak Tasci, Faysal Dane, Ali Osman Kaya, Musa Baris Aykan, Yakup Ergun, Sedat Biter, Omer Dizdar, Umut Disel, Fatih Selcukbiricik, Fatih Kose, Omer Fatih Olmez, Gokhan Demir, Suayib Yalcin, Ahmet Bilici

Subjects: Get full text

Case Report: Pathologic complete response in a patient with simultaneous diagnoses of resectable NSCLC and myeloid neoplasm with PDGFRA rearrangement treated with concurrent neoadj... by Chad B. Sussman, Minal Shah, Kausha Amin, Rachel Fanaroff, Eric Krause, Vu H. Duong, Samuel Rosner

Subjects: Get full text

Combined treatment with surgery and immune checkpoint inhibitor extended survival in a case of gastric intramural metastasis from esophageal cancer: a case report by Ayako Wakasugi, Yasue Kimura, Keita Natsugoe, Tomonori Nakanoko, Kentaro Nonaka, Sho Nambara, Qingjiang Hu, Ryota Nakanishi, Mitsuhiko Ota, Eiji Oki, Yoshinao Oda, Tomoharu Yoshizumi

Subjects: Get full text

Efficacy and safety of taxane plus ramucirumab for advanced gastric cancer after chemotherapy plus nivolumab by Toshihiko Matsumoto, Tatsuki Ikoma, Chinatsu Makiyama, Tomoyo Yasuda, Shogen Boku, Akio Nakasya, Nobuhiro Shibata, Hiroki Nagai, Takao Tsuduki, Yusuke Matsumoto, Hisateru Yasui, Reiji Higashi, Akitoshi Sasamoto, Hironaga Satake, Kentaro Inoue, Masashi Kanai, Makoto Yamasaki

Subjects: Get full text

Disproportionality analysis of adverse events associated with ipilimumab and nivolumab combination therapy based on FAERS database by Xianyu Dai, Hongliang Cao, Jiajun Li, Tao Zhang, Yuchuan Hou

Subjects: Get full text

Nivolumab in two cases of refractory mycosis fungoides erythroderma by Ewa Chmielowska

Subjects: “…nivolumab…”
Get full text

PD-1 Blockade with Nivolumab as a New Immunotherapy for Classical Hodgkin’s Lymphoma by EA Demina

Subjects: “…nivolumab…”
Get full text

Combatting mucosal melanoma: recent advances and future perspectives by Helen Tyrrell, Miranda Payne

Subjects: Get full text

Pathologic complete response after laparoscopic surgery following treatment with nivolumab and ipilimumab for anticancer drug-resistant MSI-high descending colon cancer: a case rep... by Hiroshi Sawayama, Yuji Miyamoto, Katsuhiro Ogawa, Mayuko Ohuchi, Yuki Hisano, Moeko Kato, Hiroki Tubakihara, Naoya Yoshida, Hideo Baba

Subjects: “…Nivolumab…”
Get full text

A rare immune-related mesenteric and retroperitoneal serositis in a multirefractory Hodgkin lymphoma patient successfully treated with chylolymphostatic surgery by Matteo D'Addona, Luca Pezzullo, Corradino Campisi, Corrado Cesare Campisi, Valentina Giudice, Vincenzo Ciccone, Roberto Guariglia, Bianca Serio, Carmine Selleri

Subjects: Get full text

Receptor occupancy assessment and interpretation in terms of quantitative systems pharmacology: nivolumab case study by Dmitry Shchelokov, Oleg Demin Jr

Subjects: Get full text

PERIPHERAL BLOOD MONONUCLEAR DNA DAMAGE IDENTIFIED BY THE «СOMET» METHOD, AS A POSSIBLE INDICATOR OF SENSITIVITY OF MELANOMA TO IMMUNOTHERAPY WITH NIVOLUMAB by E. V. Tsyrlina, T. E. Poroshina, A. P. Oganesyan, S. A. Protsenko, L. M. Bershtein

Subjects: Get full text

A case of long-term survival treated with three metastasectomies and two subsequent adjuvant nivolumab therapies for recurrent malignant melanoma of the esophagus by Keita Hanada, Shigeru Tsunoda, Motoo Nomura, Shintaro Fujimura, Yojiro Yutaka, Tatsuto Nishigori, Shigeo Hisamori, Hisatsugu Maekewa, Nobuaki Hoshino, Atsushi Itami, Eiji Tanaka, Kazutaka Obama

Subjects: Get full text